Molecular chaperones affect GTP cyclohydrolase I mutations in dopa-responsive dystonia
β Scribed by Wuh-Liang Hwu; Mei-Yi Lu; Kuo-Yuan Hwa; Shu-Wen Fan; Yu-May Lee
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 154 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
β¦ Synopsis
Unstable GTP cyclohydrolase I (GCH) mutations in dopa-responsive dystonia (DRD) can exert a dominant-negative effect in the HeLa cell model, but in a batch of cells this effect could not be shown. Through differential display, we found a higher Hsc70 expression in the non-dominant-negative cells. We further demonstrated that ectopic expression of Hsp40/Hsp70 stabilized the GCH mutant G201E. Moreover, Hsp90 inhibitor geldanamycin destroyed the wild-type GCH level, and heat shock increased the synthesis of GCH protein. Therefore, the dominant-negative effect produced by unstable proteins would be susceptible to the status of molecular chaperones, which could be the modifying genes and therapeutic targets for DRD and other genetic diseases.
π SIMILAR VOLUMES
Hereditary progressive dystonia (HPD) is caused by the mutant gene encoding GTP cyclohydrolase I (GCH). The clinical presentation of this disease varies considerably, and many cases appear to be sporadic. We have previously proposed that this clinical variation may be due to digetential expression o
We describe a patient with a combination of dystonic and parkinsonian signs. Paraclinical studies revealed a mutation in the GTP cyclohydrolase I gene (GCH1) and a decrease in [ 123 I]-N--fluoropropyl-2β€-carbomethoxy-3β€-(4iodophenyl) nortropane ( 123 I-FP-CIT) binding ratios indicative of Parkinson'
Mutations in the GTP-cyclohydrolase I (GCH) gene have been identified as a cause of two disorders: autosomal dominant hereditary progressive dystonia/dopa-responsive dystonia (HPD/DRD) and autosomal recessive GCH-deficient hyperphenylalaninemia (HPA). Detailed clinical descriptions and genetic analy
## Abstract We describe the clinical and molecular correlates in two Italian families with dopaβresponsive dystonia (DRD) and the same novel mutation of GTPβcyclohydrolase I (GCHβI) gene. Thirtyβfive subjects were examined and the genotype correlated to phenotype. Childhood onset foot dystonia is p